Vivimed Labs Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 18.30 | 26.73 | 34.24 |
| Operating Expense | 18.48 | 25.06 | 34.41 |
| Net Profit | -5.50 | -4.42 | -6.97 |
| Net Profit Margin | -30.05 | -16.54 | -20.36 |
| Earning Per Share | -0.66 | -0.53 | -0.84 |
| EBIDTA | -0.18 | 1.67 | -0.17 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 18.30 |
| Operating Expense | 18.48 |
| Net Profit | -5.50 |
| Net Profit Margin | -30.05 |
| Earning Per Share | -0.66 |
| EBIDTA | -0.18 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 103.60 | 136.80 | 176.83 |
| Operating Expenses Annual | 118.12 | 170.44 | 365 |
| Operating Profit Annual | -10.33 | -24.07 | -187.94 |
| Interest Annual | 2.53 | 1.90 | 35.28 |
| Depreciation | 16.11 | 16.09 | 15.38 |
| Net Profit Annual | -31.50 | -44.38 | -328.01 |
| Tax Annual | TBA | TBA | -2.12 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 103.60 |
| Operating Expenses Annual | 118.12 |
| Operating Profit Annual | -10.33 |
| Interest Annual | 2.53 |
| Depreciation | 16.11 |
| Net Profit Annual | -31.50 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.14 | 3.35 | 6.78 |
| Cash Flow from Operations | 5.73 | -96.52 | 32.87 |
| Cash Flow from Investing | -4.06 | 99.83 | -1.60 |
| Cash Flow from Financing | -2.53 | -5.51 | -34.70 |
| Cash Flow at the End | 0.29 | 1.15 | 3.35 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 1.14 |
| Cash Flow from Operations | 5.73 |
| Cash Flow from Investing | -4.06 |
| Cash Flow from Financing | -2.53 |
| Cash Flow at the End | 0.29 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | -9.97 | -17.22 | -106.13 |
| PBIT Margin (%) | -27.95 | -30.68 | -166.59 |
| PBT Margin (%) | -16.95 | -17.95 | -161.90 |
| Net PROFIT Margin (%) | -30.41 | -32.44 | -185.49 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -5.47 | -6.81 | -38.95 |
| Total Debt / Equity (X) | 10.44 | 5.13 | 1.43 |
| Asset Turnover Ratio (%) | 0.18 | 0.21 | 0.21 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | -9.97 |
| PBIT Margin (%) | -27.95 |
| PBT Margin (%) | -16.95 |
| Net PROFIT Margin (%) | -30.41 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -5.47 |
| Total Debt / Equity (X) | 10.44 |
| Asset Turnover Ratio (%) | 0.18 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 315.28 | 326.32 | 342.86 |
| Total Current Assets Annual | 247.78 | 275.72 | 271.16 |
| Non Current Assets Annual | 391.18 | 405.75 | 524.66 |
| Total Shareholders Funds Annual | 58.49 | 89.41 | 133.31 |
| Total Assets Annual | 638.95 | 681.47 | 795.82 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 315.28 |
| Total Current Assets Annual | 247.78 |
| Non Current Assets Annual | 391.18 |
| Total Shareholders Funds Annual | 58.49 |
| Total Assets Annual | 638.95 |
EPS (INR)
Expected
0.00
Reported
-0.66
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
